Up Next
Back to Show
Amanpour & Co.
A New Pill Finally Offers Hope for Pancreatic Cancer
A medical breakthrough is doubling the survival time for patients with one of the most aggressive forms of cancer. A new pill taken daily to treat pancreatic cancer has shown positive results in a study with 500 patients. Scientists found the drug reduced the risk of death by 60% compared with chemotherapy. Dr. Mark Goldsmith, CEO of the biotech company that funded the study, joins the show.
Support Provided By
